Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.22.2.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Operating activities:    
Consolidated net income $ 591.1 $ 625.5
Adjustments to reconcile consolidated net income to net cash provided by operating activities:    
Depreciation and amortization 424.1 354.9
Stock-based compensation expense 50.4 44.8
Deferred income taxes 47.9 12.6
(Gain) loss on fair market value adjustment and gain on sale of equity investment (20.2) 0.1
Gain on divestiture 0.0 (0.2)
Changes in assets and liabilities, excluding effects of acquisitions:    
Accounts receivable, net (133.6) (54.9)
Other assets, current and long-term (32.0) 5.1
Current and long term liabilities, excluding debt (496.0) (38.4)
Cash provided by operating activities 431.7 949.5
Investing activities:    
Capital expenditures (468.4) (332.9)
Acquisitions, net of cash acquired (437.5) (1,108.9)
Cash received from divestitures 98.8 1.5
Cash used in investing activities (807.1) (1,440.3)
Financing activities:    
Net short-term (repayments) borrowings (162.1) 499.2
Payments on long-term debt 0.0 (1,100.2)
Borrowings on long-term debt 749.3 1,697.3
Treasury stock purchases 0.0 (69.9)
Dividends paid to Equifax shareholders (143.3) (142.6)
Dividends paid to noncontrolling interests (2.5) (6.5)
Proceeds from exercise of stock options and employee stock purchase plan 13.5 33.4
Payment of taxes related to settlement of equity awards (33.0) (43.9)
Purchase of noncontrolling interests 0.0 (11.2)
Debt issuance costs 5.4 13.2
Cash provided by financing activities 416.5 842.4
Effect of foreign currency exchange rates on cash and cash equivalents (24.1) (10.7)
Decrease in cash and cash equivalents 17.0 340.9
Cash and cash equivalents, beginning of period 224.7 1,684.6
Cash and cash equivalents, end of period $ 241.7 $ 2,025.5